Search

Search Results

1. Systemic Lupus Erythematosus in Children

   Systemic lupus erythematosus (SLE) is a systemic autoimmune disease, that mainly affects skin, joints and kidneys but can affect any organ in the...

   Kunal Chandwar, Amita Aggarwal in Indian Journal of Pediatrics

   Article 15 September 2023
   

2. Vascular damage in systemic lupus erythematosus

   Vascular disease is a major cause of morbidity and mortality in patients with systemic autoimmune diseases, particularly systemic lupus erythematosus...

   William G. Ambler, Mariana J. Kaplan in Nature Reviews Nephrology

   Article 03 January 2024
   

3. Retinal sublayer analysis in juvenile systemic lupus erythematosus without lupus retinopathy

   Introduction

   We aimed to analyze the thicknesses of the retinal sublayer and peripapillary retinal nerve fiber layer (pRNFL) in patients with juvenile...

   Sisi Xu, Yu Zhang in Clinical Rheumatology

   Article 10 July 2024
   

4. Children systemic lupus erythematosus-associated pancreatitis

   Objective

   To early recognise and improve the prognosis of children systemic lupus erythematosus (cSLE)-associated pancreatitis by summarising and...

   Dan Zhang, Jianming Lai, ... Li Meng in Arthritis Research & Therapy

   Article Open access 17 January 2024

5. Clinical characteristics of systemic lupus erythematosus patients with adrenal hemorrhage

   Introduction

   Adrenal hemorrhage (AH) is a rare condition and severe cases can lead to acute adrenal insufficiency with potentially life-threatening...

   Lan Gao, Lingling Zhang, ... Mengtao Li in Clinical Rheumatology

   Article 09 May 2024
   

6. Targeting Interferon Signalling in Systemic Lupus Erythematosus: Lessons Learned

   The development of new medicines for systemic lupus erythematosus (SLE) has not addressed unmet clinical need, with only three drugs receiving...

   Sarah A. Jones, Eric F. Morand in Drugs

   Article Open access 28 May 2024
   

7. Atherosclerosis in Systemic Lupus Erythematosus

   Purpose of the Review

   Systemic lupus erythematosus (SLE) patients are at increased risk of cardiovascular disease (CVD) compared to the general...

   Rachel Tobin, Nidhi Patel, ... Ijeoma Isiadinso in Current Atherosclerosis Reports

   Article 28 September 2023
   

8. Myocardial fibrosis associates with lupus anticoagulant in patients with systemic lupus erythematosus

   Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that carries increased risk of cardiovascular disease; however, the underlying...

   Katrine A. Myhr, Amanda H. Zinglersen, ... Søren Jacobsen in The International Journal of Cardiovascular Imaging

   Article Open access 09 October 2023
   

9. Type I interferon pathway in pediatric systemic lupus erythematosus

   Background

   The role of type I interferon (IFN-I) signaling in systemic lupus erythematosus (SLE) has been well established. However, unanswered...

   Yu Zhou, Hong-Mei Song in World Journal of Pediatrics

   Article Open access 25 June 2024
   

10. Subclinical choroidal involvement in Systemic Lupus Erythematosus

    Purpose

    To assess the choroidal status of Systemic Lupus Erythematosus (SLE) patients using Optical Coherence Tomography (OCT) and OCT-Angiography.

    ...

    André Ferreira, Luísa Viveiros, ... Pedro Menéres in Graefe's Archive for Clinical and Experimental Ophthalmology

    Article 23 May 2024
    

11. Systemic lupus erythematosus: latest insight into etiopathogenesis

    Systemic lupus erythematosus (SLE) is a complex autoimmune disorder of unknown etiology. Multifactorial interaction among various susceptible factors...

    Akhil Akhil, Rohit Bansal, ... Archana Bhatnagar in Rheumatology International

    Article 24 May 2023
    

12. Oral Consequences of Systemic Lupus Erythematosus: an Update

    Purpose of Review

    Systemic lupus erythematosus (SLE) is an autoimmune disease affecting multiple organs that has been associated with various oral...

    Pierre-Yves Gegout, Reem Wabbi, ... Olivier Huck in Current Oral Health Reports

    Article 06 November 2023
    

13. Association of Thrombotic Markers With Severity of Pediatric-Onset Systemic Lupus Erythematosus

    Objective

    To assess the relation of thrombotic markers, thrombomodulin and D-dimer levels to the disease severity in pediatric onset systemic lupus...

    Sheren Esam Maher, Ahmed Ragab Abdul-Badia, ... Suzan Omar Mousa in Indian Pediatrics

    Article 20 July 2023

14. Precision medicine in systemic lupus erythematosus

    Systemic lupus erythematosus (SLE) is an autoimmune disease that has diverse clinical manifestations, ranging from restricted cutaneous involvement...

    Serena Fasano, Alessandra Milone, ... Francesco Ciccia in Nature Reviews Rheumatology

    Article 11 April 2023
    

15. The gut microbiome in systemic lupus erythematosus: lessons from rheumatic fever

    For more than a century, certain bacterial infections that can breach the skin and mucosal barriers have been implicated as common triggers of...

    Gregg J. Silverman, Doua F. Azzouz, ... Abhimanyu Amarnani in Nature Reviews Rheumatology

    Article 06 February 2024
    

16. No clear influence of treatment escalation on flare prevention in serologically active clinically quiescent patients with systemic lupus erythematosus: a retrospective cohort study

    This study aimed to clarify the efficacy and safety of treatment escalation by initiating therapeutic agents in serologically active clinically...

    Masahiro Ayano, Akie Hirata, ... Hiroaki Niiro in Rheumatology International

    Article 26 April 2024
    

17. Salt Behind the Scenes of Systemic Lupus Erythematosus and Rheumatoid Arthritis

    Purpose of Review

    Sodium is vital for human health. High salt intake is a global health problem and is associated with cardiovascular morbidity and...

    Baris Afsar, Rengin Elsurer Afsar in Current Nutrition Reports

    Article 18 November 2023
    

18. Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus

    Background

    Remission is a key treatment target in systemic lupus erythematosus (SLE) management. Given the direct correlation between lupus flares and...

    Takehiro Nakai, Nanase Honda, ... Masato Okada in Arthritis Research & Therapy

    Article Open access 09 March 2024
    

19. Diagnostic challenge of tuberculosis in systemic lupus erythematosus: a case report and literature review

    Patients with systemic lupus erythematosus (SLE) are at increased risk of tuberculosis (TB) infection due to immune dysfunction and immunosuppressive...

    Svitlana Smiyan, Bohdan Koshak, ... Anastasia Bilukha in Rheumatology International

    Article 31 July 2023
    

20. Safety and efficacy of telitacicept in refractory systemic lupus erythematosus patients who failed treatment with belimumab

    Objective

    This study aimed to determine the effect and safety of telitacicept, an antagonist of BLyS/APRIL-mediated B cell activation, in patients...

    Qiuyu Fan, Huiqin Yang, Ya Liu in Zeitschrift für Rheumatologie

    Article Open access 29 December 2023